Trials / Completed
CompletedNCT01186432
Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Forsight Vision4 · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the preliminary safety and efficacy of PDS 1.0 in patients with neovascular AMD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PDS 1.0 |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2012-05-01
- Completion
- 2014-04-01
- First posted
- 2010-08-23
- Last updated
- 2015-03-05
Locations
1 site across 1 country: Latvia
Source: ClinicalTrials.gov record NCT01186432. Inclusion in this directory is not an endorsement.